BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35498155)

  • 1. FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance.
    Wang Z; Sun BS; Chen ZS; Zhao KK; Wang YL; Meng FX; Zhang Y
    Anal Cell Pathol (Amst); 2022; 2022():9675466. PubMed ID: 35498155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXA1 co-activates circODC1 and ODC1 in HPV-positive cervical cancer cell growth.
    Jin R; Li H; Nan S; Wang H
    Syst Biol Reprod Med; 2024 Dec; 70(1):113-123. PubMed ID: 38743820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
    Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
    Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals.
    Zhang XL; Wang HS; Liu N; Ge LC
    Arch Biochem Biophys; 2015 Nov; 585():10-16. PubMed ID: 26363213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
    Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
    Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients.
    He S; Zhang J; Zhang W; Chen F; Luo R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):175. PubMed ID: 29208003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways.
    Liu H; Song M; Sun X; Zhang X; Miao H; Wang Y
    Bioengineered; 2021 Dec; 12(1):565-577. PubMed ID: 33557670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Forkhead box A1 suppresses the tumorigenesis and progression of human colon cancer cells through regulating the phosphatase and tensin homolog/Akt pathway.
    Pan J; Xu Z; Xu M; Lin X; Lin B; Lin M
    J Int Med Res; 2020 Dec; 48(12):300060520971453. PubMed ID: 33296605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead-box A1 induces cell senescence in endometrial cancer by regulating p16INK4a.
    Wang J; Bian Y; Liao Y; Xia Y; Wan X
    Oncol Rep; 2016 Aug; 36(2):795-802. PubMed ID: 27349269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
    J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation.
    Yue M; Yun Z; Li S; Yan G; Kang Z
    RNA Biol; 2021 Nov; 18(11):1981-1995. PubMed ID: 33530829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead‑box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
    Park YL; Kim SH; Park SY; Jung MW; Ha SY; Choi JH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
    Int J Oncol; 2019 Jun; 54(6):2169-2178. PubMed ID: 31081047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization.
    Tang DE; Dai Y; Xu Y; Lin LW; Liu DZ; Hong XP; Ou ML; Jiang HW; Xu SH
    Carcinogenesis; 2020 Mar; 41(1):56-66. PubMed ID: 31046116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
    Fu X; Jeselsohn R; Pereira R; Hollingsworth EF; Creighton CJ; Li F; Shea M; Nardone A; De Angelis C; Heiser LM; Anur P; Wang N; Grasso CS; Spellman PT; Griffith OL; Tsimelzon A; Gutierrez C; Huang S; Edwards DP; Trivedi MV; Rimawi MF; Lopez-Terrada D; Hilsenbeck SG; Gray JW; Brown M; Osborne CK; Schiff R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6600-E6609. PubMed ID: 27791031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.